New T Cell Therapy reagent for mRNA delivery using Lipid Nanoparticles

28 May, 2021 | Newsletters
New T Cell Therapy reagent for mRNA delivery using Lipid Nanoparticles
Precision NanoSystems is proud to announce that the GenVoy-ILM™ T Cell Kit for mRNA is now available to enable lipid nanoparticle (LNP)-based ex vivo gene transfer into T cells. Scientists can now use mRNA-LNP to efficiently and reproducibly generate high yields of engineered primary human T cells using a simple workflow.  
Read the full press release here

   
One preparation is ready in under 5 minutes, and the resulting mRNA-LNPs can be seamlessly integrated into standard T cell culture workflows. The GenVoy-ILM T Cell Kit for mRNA and the NanoAssemblr® Spark™  enable the preparation of mRNA encapsulating LNP optimized for delivery to activated primary human T cells. It can be used at various stages of cell therapy research from discovery to preclinical development.  

mRNA-LNP generated from the GenVoy-ILM T Cell Kit for mRNA leverage endogenous cellular uptake mechanisms  

View the data    

Webinar: Rethink T Cell Therapy with Lipid Nanoparticles 
Learn more about how the GenVoy-ILM T Cell Kit for mRNA can empower your research.
Key learnings:
•    Review of current ex vivo gene delivery strategies for cell therapies
•    Introduction of GenVoy lipid nanoparticle delivery platform
•    Presentation of data in T cells comparing the GenVoy-ILM T Cell Kit for mRNA with electroporation  
To watch the recording click here
Request training or a demo
Click here for sample testing
Click here for service support